Susquehanna Portfolio Strategies’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
+80,089
New +$2.25M 0.04% 423
2026
Q1
– Sell
-86,325
Closed -$3.42M – 982
2025
Q4
$3.42M Buy
+86,325
New +$3.16M 0.05% 379
2024
Q1
– Sell
-19,050
Closed -$680K – 796
2023
Q4
$680K Buy
+19,050
New +$709K 0.01% 695

Other funds holding ATRC

Susquehanna Portfolio Strategies's ATRC Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in AtriCure (ATRC) in Q2 2026: 80,089 shares worth $2.24M. The stake represents 0.04% of the portfolio and ranks #423 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in ATRC as recently as Q4 2025.

Susquehanna Portfolio Strategies first reported a position in ATRC in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.42M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Susquehanna Portfolio Strategies held 80,089 shares of AtriCure worth $2.24M as of Q2 2026.
  • AtriCure was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • AtriCure made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #423 holding.
  • Susquehanna Portfolio Strategies first reported a position in AtriCure in Q4 2023 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's AtriCure position peaked at $3.42M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.